1-7 of 7
Tanya M. Wildes, MDMSCI
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cognitive Function in Older Adults with Hematological Malignancies

Thuy Thi Koll, MD, Noel S. Bruner, Vijaya R. Bhatt, MBBS, Tanya M. Wildes, MDMSCI, Apar K Ganti, MD, Diane K. Hendricks, LCSW, Dennis P. McNeilly, Psy.D
Journal: Blood
Blood (2017) 130 (Supplement 1): 3440.
https://doi.org/10.1182/blood.V130.Suppl_1.3440.3440
Published: 2017
Journal Articles

Impact of a Brief Touchscreen Based Modified Geriatric Assessment on the Care of Older Adults with Multiple Myeloma

Nitya Nathwani, Sandra Kurtin, PhD, ANP-C, AOCN, Brea Lipe, MD, Supriya Mohile, MD, Donna D Catamero, ANP-BC, OCN, CCRC, Tanya M. Wildes, MDMSCI, Debra Wujcik, PhD RN, FAAN, Agnes Davis, Laura Digiovanni, MA, Carrie T Stricker, PhD RN, Arti Hurria
Journal: Blood
Blood (2017) 130 (Supplement 1): 3401.
https://doi.org/10.1182/blood.V130.Suppl_1.3401.3401
Published: 2017
Journal Articles

Statin Use Is Associated with Decreased Mortality in Multiple Myeloma— a SEER Medicare Study

Shivaprasad Manjappa, MD, Mark A. Fiala, BS, Pavan Kumar Bhamidipati, MBBS, MD, Keith E. Stockerl-Goldstein, MD, Mark A. Schroeder, MD, Armin Ghobadi, MD, Ravi Vij, MDMBA, Tanya M. Wildes, MDMSCI
Journal: Blood
Blood (2017) 130 (Supplement 1): 1860.
https://doi.org/10.1182/blood.V130.Suppl_1.1860.1860
Published: 2017
Journal Articles

Race Is Associated with Bortezomib but Not Lenalidomide Utilization during First-Line Treatment of Multiple Myeloma

Mark A. Fiala, BS, Sikander Ailawadhi, Ravi Vij, MDMBA, Tanya M. Wildes, MDMSCI
Journal: Blood
Blood (2017) 130 (Supplement 1): 862.
https://doi.org/10.1182/blood.V130.Suppl_1.862.862
Published: 2017
Journal Articles

Measuring Cardiopulmonary Complications of Carfilzomib Treatment and Associated Risk Factors Using the SEER-Medicare Database

Bita Fakhri, MDMPH, Mark A. Fiala, BS, Ravi Vij, MDMBA, Tanya M. Wildes, MDMSCI
Journal: Blood
Blood (2017) 130 (Supplement 1): 3103.
https://doi.org/10.1182/blood.V130.Suppl_1.3103.3103
Published: 2017
Journal Articles

A Cost-Benefit Analysis of Bortezomib, Lenalidomide, and Bortezomib/Lenalidomide Combination Therapy for Newly Diagnosed Multiple Myeloma

Mark A. Fiala, BS, Tanya M. Wildes, MDMSCI, Gunjan L. Shah, MD, Armin Ghobadi, MD, Mark A. Schroeder, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MDMBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3108.
https://doi.org/10.1182/blood.V130.Suppl_1.3108.3108
Published: 2017
Journal Articles

Overexpression of EZH2 in Multiple Myeloma Is Associated with Poor Prognosis Regardless of Treatment with Novel Agents or High-Dose Chemotherapy

Mark A. Schroeder, MD, Mark A. Fiala, BS, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Tanya M. Wildes, MDMSCI, Ravi Vij, MDMBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4335.
https://doi.org/10.1182/blood.V130.Suppl_1.4335.4335
Published: 2017